Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jon Matsumura

Concepts (463)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Vessel Prosthesis Implantation
88
2026
228
15.090
 Why?
Aortic Aneurysm, Abdominal
72
2026
167
11.690
 Why?
Blood Vessel Prosthesis
60
2026
140
10.570
 Why?
Endovascular Procedures
53
2026
384
10.150
 Why?
Aortic Aneurysm, Thoracic
35
2026
139
7.830
 Why?
Stents
68
2025
556
7.690
 Why?
Aorta, Thoracic
27
2026
286
4.600
 Why?
Carotid Stenosis
23
2024
102
3.620
 Why?
Prosthesis Design
41
2026
357
3.450
 Why?
Iliac Aneurysm
9
2024
19
3.320
 Why?
Vascular Surgical Procedures
19
2018
339
2.420
 Why?
Endarterectomy, Carotid
14
2024
60
2.230
 Why?
Aortography
18
2025
52
2.160
 Why?
Vascular System Injuries
6
2024
77
2.130
 Why?
Tomography, X-Ray Computed
37
2025
2730
2.030
 Why?
Aortic Diseases
9
2025
124
1.930
 Why?
Treatment Outcome
96
2026
11679
1.920
 Why?
Iliac Artery
11
2024
55
1.830
 Why?
Angioplasty
12
2017
50
1.810
 Why?
Computed Tomography Angiography
8
2024
145
1.790
 Why?
Time Factors
57
2026
7173
1.640
 Why?
Aortic Aneurysm
9
2024
70
1.550
 Why?
Aortic Rupture
12
2022
28
1.500
 Why?
Stroke
18
2024
1256
1.480
 Why?
Aged, 80 and over
57
2026
8265
1.390
 Why?
Angioplasty, Balloon
9
2013
94
1.370
 Why?
Aged
107
2026
25913
1.300
 Why?
Aorta, Abdominal
9
2025
52
1.150
 Why?
Postoperative Complications
35
2025
2919
1.130
 Why?
Risk Factors
45
2026
10779
1.100
 Why?
Sarcopenia
2
2019
91
1.060
 Why?
Endoleak
11
2025
17
1.060
 Why?
Prospective Studies
39
2026
7990
0.960
 Why?
Prosthesis Failure
11
2017
127
0.960
 Why?
Middle Aged
82
2026
35875
0.940
 Why?
Vascular Patency
13
2025
121
0.920
 Why?
Humans
183
2026
144759
0.910
 Why?
Subclavian Artery
6
2022
28
0.900
 Why?
Male
122
2026
72315
0.870
 Why?
United States
41
2025
15966
0.800
 Why?
Myocardial Infarction
5
2024
1209
0.790
 Why?
Female
115
2026
78271
0.780
 Why?
Predictive Value of Tests
11
2025
2115
0.750
 Why?
Femoral Artery
4
2013
190
0.750
 Why?
Vena Cava Filters
5
2023
64
0.740
 Why?
Ulcer
3
2014
37
0.690
 Why?
Risk Assessment
21
2024
3671
0.680
 Why?
Population Surveillance
2
2021
485
0.660
 Why?
Foreign-Body Migration
3
2017
32
0.640
 Why?
Alloys
3
2024
38
0.610
 Why?
Ischemia
5
2018
421
0.610
 Why?
Retrospective Studies
44
2025
17066
0.610
 Why?
Popliteal Artery
4
2015
62
0.580
 Why?
Psoas Muscles
1
2018
14
0.580
 Why?
Peripheral Arterial Disease
2
2018
503
0.570
 Why?
Marfan Syndrome
1
2019
46
0.570
 Why?
Frailty
2
2019
198
0.570
 Why?
Reoperation
13
2020
630
0.560
 Why?
Body Composition
2
2019
706
0.550
 Why?
Doxycycline
4
2025
62
0.520
 Why?
Societies, Medical
5
2020
887
0.520
 Why?
Chlorhexidine
1
2017
23
0.510
 Why?
Decontamination
1
2017
32
0.500
 Why?
Anti-Infective Agents, Local
1
2017
40
0.500
 Why?
Elective Surgical Procedures
8
2020
201
0.480
 Why?
Health Care Costs
3
2014
427
0.480
 Why?
Wounds, Nonpenetrating
6
2024
316
0.460
 Why?
Embolization, Therapeutic
2
2022
242
0.450
 Why?
Infection Control
1
2017
172
0.450
 Why?
Education, Medical, Continuing
2
2014
132
0.440
 Why?
Radiography, Interventional
5
2019
130
0.430
 Why?
Thoracic Injuries
3
2024
72
0.430
 Why?
Follow-Up Studies
26
2024
5408
0.420
 Why?
Program Development
2
2014
370
0.410
 Why?
Patient Readmission
3
2014
758
0.410
 Why?
Surgical Wound Infection
1
2017
316
0.400
 Why?
Lower Extremity
1
2018
438
0.400
 Why?
Vascular Diseases
2
2014
251
0.400
 Why?
Vascular Calcification
2
2025
110
0.380
 Why?
Kaplan-Meier Estimate
10
2019
965
0.380
 Why?
Health Expenditures
1
2014
194
0.380
 Why?
Congresses as Topic
1
2014
221
0.370
 Why?
Carotid Artery Diseases
3
2005
69
0.370
 Why?
Clinical Trials as Topic
5
2026
1053
0.370
 Why?
Skin
1
2017
755
0.360
 Why?
Asymptomatic Diseases
5
2024
102
0.360
 Why?
Patient Selection
7
2021
719
0.360
 Why?
Embolic Protection Devices
1
2012
12
0.350
 Why?
Constriction, Pathologic
7
2023
248
0.340
 Why?
Minimally Invasive Surgical Procedures
7
2009
192
0.330
 Why?
Thoracic Outlet Syndrome
3
2001
14
0.330
 Why?
Arterial Occlusive Diseases
3
2008
90
0.330
 Why?
Thromboembolism
1
2012
125
0.330
 Why?
Pulmonary Embolism
2
2005
244
0.330
 Why?
Severity of Illness Index
9
2024
2925
0.320
 Why?
Intracranial Embolism
1
2010
34
0.320
 Why?
Ultrasonography, Doppler, Duplex
10
2017
40
0.320
 Why?
Ultrasonography, Interventional
3
2001
160
0.320
 Why?
Disease Progression
6
2023
2847
0.310
 Why?
Filtration
1
2010
70
0.310
 Why?
Peripheral Vascular Diseases
2
2004
104
0.310
 Why?
Venous Thrombosis
5
2005
194
0.300
 Why?
Muscle, Skeletal
1
2019
1795
0.290
 Why?
Adult
37
2024
40449
0.290
 Why?
Chi-Square Distribution
5
2014
529
0.290
 Why?
Radiography
7
2012
844
0.290
 Why?
Stainless Steel
2
2024
21
0.270
 Why?
Iliac Vein
2
2006
15
0.270
 Why?
Thrombosis
4
2018
393
0.270
 Why?
Regional Blood Flow
4
2018
514
0.270
 Why?
Survival Rate
10
2016
2089
0.270
 Why?
Health Status
4
2026
836
0.270
 Why?
Paraparesis
2
2008
7
0.260
 Why?
Spinal Cord Ischemia
2
2010
60
0.250
 Why?
Hospitals, University
1
2007
176
0.250
 Why?
Graft Occlusion, Vascular
4
2018
42
0.250
 Why?
Blood Proteins
2
2025
249
0.230
 Why?
Hospital Mortality
4
2020
1030
0.230
 Why?
Endpoint Determination
1
2026
83
0.230
 Why?
Angiography
5
2017
208
0.230
 Why?
Ankle Brachial Index
2
2018
41
0.230
 Why?
Epidemiologic Research Design
1
2005
29
0.230
 Why?
Length of Stay
6
2024
1337
0.230
 Why?
Amino Acid Oxidoreductases
1
2024
19
0.220
 Why?
Protein-Lysine 6-Oxidase
1
2024
14
0.220
 Why?
Incisional Hernia
1
2024
3
0.210
 Why?
Retreatment
2
2021
77
0.210
 Why?
Erectile Dysfunction
2
2023
38
0.210
 Why?
Femoral Vein
3
2001
38
0.200
 Why?
Matrix Metalloproteinase 3
1
2023
27
0.200
 Why?
Preoperative Care
3
2017
379
0.200
 Why?
Reproducibility of Results
4
2025
3409
0.190
 Why?
Multicenter Studies as Topic
3
2014
405
0.190
 Why?
Matrix Metalloproteinase 9
1
2023
132
0.190
 Why?
Paraplegia
4
2011
61
0.180
 Why?
Catheterization, Peripheral
3
2009
118
0.180
 Why?
Comorbidity
7
2019
1658
0.180
 Why?
Carotid Artery, Internal
5
2008
45
0.180
 Why?
Equipment Design
6
2011
530
0.180
 Why?
Prosthesis Implantation
2
2002
153
0.180
 Why?
Aftercare
2
2020
223
0.170
 Why?
Double-Blind Method
3
2023
2029
0.170
 Why?
Odds Ratio
3
2014
1075
0.170
 Why?
Feasibility Studies
7
2022
1095
0.170
 Why?
Eligibility Determination
1
2021
68
0.170
 Why?
Hyperglycemia
1
2024
375
0.160
 Why?
Patients' Rooms
1
2000
13
0.160
 Why?
Logistic Models
4
2015
2117
0.160
 Why?
Collateral Circulation
2
2010
19
0.160
 Why?
Clinical Competence
6
2019
1244
0.160
 Why?
Abdominal Oblique Muscles
1
2019
1
0.160
 Why?
Registries
2
2019
2385
0.160
 Why?
Intercostal Muscles
1
2019
4
0.160
 Why?
Cause of Death
4
2019
471
0.150
 Why?
Rectus Abdominis
1
2019
16
0.150
 Why?
United States Food and Drug Administration
3
2009
203
0.150
 Why?
Oleic Acids
1
1999
12
0.150
 Why?
Superficial Back Muscles
1
2019
16
0.150
 Why?
Spinal Fusion
1
2022
260
0.150
 Why?
Credentialing
1
2019
21
0.150
 Why?
Specialties, Surgical
1
2020
82
0.150
 Why?
Cost-Benefit Analysis
2
2020
634
0.150
 Why?
Aneurysm, Ruptured
2
2013
38
0.150
 Why?
Observer Variation
2
2018
355
0.140
 Why?
Frail Elderly
1
2019
134
0.140
 Why?
Proteomics
1
2025
1195
0.140
 Why?
Liposomes
1
2000
250
0.140
 Why?
Phosphatidylcholines
1
1999
131
0.140
 Why?
Genetic Therapy
1
2000
313
0.140
 Why?
Protease Inhibitors
1
2019
102
0.140
 Why?
Disease-Free Survival
3
2017
769
0.140
 Why?
Electronic Mail
1
2018
61
0.140
 Why?
Surgeons
1
2022
339
0.140
 Why?
Gene Transfer Techniques
1
1999
185
0.140
 Why?
Curriculum
1
2005
1059
0.140
 Why?
Quality of Life
5
2026
3185
0.130
 Why?
Limb Salvage
1
2018
70
0.130
 Why?
Neck Muscles
1
1997
21
0.130
 Why?
Ribs
1
1997
35
0.130
 Why?
Anatomic Landmarks
1
2017
31
0.130
 Why?
Anti-Bacterial Agents
2
2020
1907
0.130
 Why?
Clavicle
1
1997
38
0.130
 Why?
Blood Vessels
1
1999
171
0.130
 Why?
Administration, Cutaneous
1
2017
125
0.130
 Why?
Critical Illness
3
2018
891
0.120
 Why?
Axillary Artery
1
1996
13
0.120
 Why?
Quality Assurance, Health Care
2
2019
340
0.120
 Why?
Bile Pigments
1
1996
2
0.120
 Why?
Cholagogues and Choleretics
1
1996
5
0.120
 Why?
Bile
1
1996
26
0.120
 Why?
Endothelium, Vascular
2
2000
965
0.120
 Why?
Cholelithiasis
1
1996
36
0.120
 Why?
Analysis of Variance
2
2016
1306
0.120
 Why?
Incidence
7
2016
2879
0.110
 Why?
Randomized Controlled Trials as Topic
4
2024
1720
0.110
 Why?
Biomarkers
2
2025
4271
0.110
 Why?
Anti-Inflammatory Agents
1
2019
474
0.110
 Why?
Antioxidants
1
2019
549
0.110
 Why?
Antihypertensive Agents
1
2019
510
0.110
 Why?
Spinal Injuries
1
1995
58
0.110
 Why?
Survival Analysis
6
2016
1382
0.110
 Why?
Evidence-Based Medicine
4
2017
732
0.110
 Why?
Chicago
3
2011
61
0.110
 Why?
Blood Glucose
1
2024
2327
0.110
 Why?
Prosthesis-Related Infections
2
2008
99
0.100
 Why?
Intermittent Claudication
1
2015
121
0.100
 Why?
Wisconsin
1
2013
99
0.100
 Why?
Age Factors
3
2024
3333
0.100
 Why?
Hospital Costs
1
2014
124
0.100
 Why?
Taurocholic Acid
1
1993
8
0.100
 Why?
Hypertension
2
2021
1263
0.100
 Why?
Physician-Patient Relations
1
2018
585
0.100
 Why?
Parenteral Nutrition, Total
1
1993
30
0.100
 Why?
Gastrointestinal Diseases
1
1995
216
0.100
 Why?
Imaging, Three-Dimensional
2
2016
583
0.100
 Why?
Aneurysm
2
2003
37
0.090
 Why?
Clinical Decision-Making
3
2021
359
0.090
 Why?
Diabetes Mellitus
1
2021
1098
0.090
 Why?
Tertiary Care Centers
1
2013
189
0.090
 Why?
Intestinal Absorption
1
1993
103
0.090
 Why?
Leg
3
1999
239
0.090
 Why?
Postoperative Care
1
2014
288
0.090
 Why?
Intraoperative Complications
3
2019
155
0.090
 Why?
Ileum
1
1993
111
0.090
 Why?
Europe
1
2013
412
0.090
 Why?
Device Approval
2
2009
19
0.090
 Why?
Communication
1
2018
965
0.090
 Why?
Permeability
2
2009
168
0.090
 Why?
Catheters
1
2011
75
0.090
 Why?
Viscera
1
2011
17
0.080
 Why?
Netherlands
2
2020
82
0.080
 Why?
Proportional Hazards Models
3
2009
1325
0.080
 Why?
Acute Disease
4
2024
1030
0.080
 Why?
Exercise Tolerance
1
2013
283
0.080
 Why?
Aneurysm, False
1
2011
45
0.080
 Why?
Vertebrobasilar Insufficiency
1
2010
10
0.080
 Why?
Bayes Theorem
2
2023
433
0.080
 Why?
Residence Characteristics
1
2013
377
0.080
 Why?
Databases as Topic
1
2010
71
0.080
 Why?
Cardiovascular Diseases
1
2022
2168
0.080
 Why?
Research Design
3
2009
1135
0.080
 Why?
Electronic Health Records
1
2018
1173
0.080
 Why?
Multivariate Analysis
1
2013
1539
0.080
 Why?
Exercise Test
1
2013
634
0.080
 Why?
Controlled Clinical Trials as Topic
1
2009
27
0.080
 Why?
Young Adult
5
2024
14105
0.080
 Why?
United States Department of Veterans Affairs
1
2014
768
0.080
 Why?
Radiography, Abdominal
2
2001
44
0.080
 Why?
Longitudinal Studies
1
2017
2947
0.080
 Why?
Hospitals, Urban
1
2010
144
0.080
 Why?
Ischemic Attack, Transient
2
2009
71
0.080
 Why?
Ambulatory Care
1
2014
600
0.080
 Why?
Genes, Reporter
2
2000
275
0.070
 Why?
Dilatation, Pathologic
2
1999
62
0.070
 Why?
Socioeconomic Factors
1
2013
1326
0.070
 Why?
Porosity
1
2009
96
0.070
 Why?
Telemedicine
1
2018
945
0.070
 Why?
Benchmarking
1
2010
188
0.070
 Why?
Plasmids
2
2000
379
0.070
 Why?
Sex Factors
2
2025
2112
0.070
 Why?
Rupture
1
2009
91
0.070
 Why?
Extremities
1
2009
140
0.070
 Why?
Carotid Arteries
1
2010
207
0.070
 Why?
Ultrasonography
4
2014
770
0.070
 Why?
Aorta
2
2022
429
0.070
 Why?
General Surgery
2
2014
207
0.070
 Why?
Anesthesiology
1
1990
175
0.070
 Why?
Coronary Artery Bypass
2
2000
268
0.070
 Why?
Treatment Failure
2
2020
365
0.070
 Why?
Carotid Artery Thrombosis
1
2007
6
0.060
 Why?
Organ Size
2
2020
463
0.060
 Why?
Equipment Safety
2
2009
38
0.060
 Why?
Patient Discharge
1
2013
983
0.060
 Why?
Animals
6
2024
38058
0.060
 Why?
Calcinosis
1
2009
234
0.060
 Why?
Delivery of Health Care
1
2014
947
0.060
 Why?
Image Processing, Computer-Assisted
2
2004
780
0.060
 Why?
Polymorphism, Single Nucleotide
1
2014
2145
0.060
 Why?
Arm
2
1997
109
0.060
 Why?
Brain Ischemia
1
2010
358
0.060
 Why?
Prostheses and Implants
1
2007
141
0.060
 Why?
Clinical Trials, Phase II as Topic
1
2005
77
0.060
 Why?
Polyesters
1
2006
80
0.060
 Why?
Hematoma
1
2005
59
0.060
 Why?
Practice Guidelines as Topic
4
2010
1560
0.060
 Why?
Vena Cava, Inferior
2
2023
81
0.060
 Why?
Recurrence
3
2017
1135
0.060
 Why?
Health Status Indicators
1
2005
166
0.050
 Why?
Renal Veins
1
2004
18
0.050
 Why?
Mesenteric Artery, Superior
1
2004
28
0.050
 Why?
Hernia, Ventral
1
2004
22
0.050
 Why?
United Kingdom
2
2003
338
0.050
 Why?
High-Throughput Screening Assays
1
2025
175
0.050
 Why?
Extracellular Matrix Proteins
1
2024
158
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2023
18
0.050
 Why?
Nephrectomy
1
2004
158
0.050
 Why?
Fluoroscopy
2
2001
176
0.050
 Why?
Data Collection
1
2006
633
0.050
 Why?
Myocytes, Smooth Muscle
1
2024
266
0.050
 Why?
Vascular Remodeling
1
2024
205
0.050
 Why?
Leadership
1
2007
408
0.050
 Why?
Cerebrovascular Disorders
2
2000
103
0.050
 Why?
Lumbosacral Region
1
2022
59
0.050
 Why?
Head and Neck Neoplasms
1
2007
558
0.050
 Why?
Mass Spectrometry
1
2025
750
0.050
 Why?
Cells, Cultured
2
2000
4154
0.050
 Why?
Illinois
3
2008
47
0.050
 Why?
Learning Curve
1
2022
70
0.050
 Why?
Muscle, Smooth, Vascular
1
2024
452
0.040
 Why?
Quality of Health Care
1
2007
691
0.040
 Why?
Arteries
1
2023
259
0.040
 Why?
Mesenteric Vascular Occlusion
1
2001
5
0.040
 Why?
Device Removal
1
2023
143
0.040
 Why?
Time
1
2002
86
0.040
 Why?
Perfusion
1
2023
250
0.040
 Why?
Delphi Technique
1
2023
329
0.040
 Why?
Mesenteric Veins
1
2001
23
0.040
 Why?
England
1
2001
111
0.040
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2025
439
0.040
 Why?
Maxillary Sinus Neoplasms
1
2001
7
0.040
 Why?
Substance-Related Disorders
1
1990
1094
0.040
 Why?
Health Status Disparities
1
2024
321
0.040
 Why?
Angiotensin Receptor Antagonists
1
2021
114
0.040
 Why?
Gene Targeting
1
2000
82
0.040
 Why?
Sensitivity and Specificity
2
2005
1985
0.040
 Why?
Costs and Cost Analysis
1
2001
219
0.040
 Why?
Peritoneum
1
2000
45
0.040
 Why?
Cerebral Angiography
1
2000
119
0.040
 Why?
Biomedical Research
1
2007
710
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2021
221
0.040
 Why?
Disease Models, Animal
2
2024
4557
0.040
 Why?
Radiotherapy
1
2001
206
0.040
 Why?
Troponin T
1
2000
65
0.040
 Why?
Internship and Residency
1
1990
1257
0.040
 Why?
Cation Exchange Resins
1
1999
7
0.040
 Why?
Intracranial Aneurysm
1
2000
103
0.040
 Why?
Spermine
1
1999
29
0.040
 Why?
Diagnosis, Differential
2
2001
1489
0.040
 Why?
Rabbits
1
2000
648
0.040
 Why?
Injury Severity Score
2
2013
600
0.040
 Why?
Arteriovenous Shunt, Surgical
1
1999
19
0.040
 Why?
Luciferases
1
1999
152
0.040
 Why?
Emergency Treatment
1
2020
124
0.040
 Why?
Monitoring, Intraoperative
1
1999
64
0.040
 Why?
Point-of-Care Systems
1
2001
187
0.040
 Why?
Echocardiography, Transesophageal
1
2000
133
0.040
 Why?
Veins
1
1999
68
0.040
 Why?
Endoscopy
1
2001
316
0.040
 Why?
Prognosis
3
2015
4282
0.040
 Why?
Practice Patterns, Physicians'
3
2019
1356
0.040
 Why?
Drug Carriers
1
1999
130
0.030
 Why?
Postoperative Period
1
1999
354
0.030
 Why?
Myocardial Contraction
1
2000
298
0.030
 Why?
Glycine
1
1999
187
0.030
 Why?
Arteriosclerosis
1
1998
84
0.030
 Why?
Subclavian Vein
1
1997
15
0.030
 Why?
Surgical Flaps
1
1999
142
0.030
 Why?
Administration, Oral
1
2020
847
0.030
 Why?
Anastomosis, Surgical
1
1998
157
0.030
 Why?
Heparin, Low-Molecular-Weight
1
1997
36
0.030
 Why?
Multiple Trauma
2
2010
116
0.030
 Why?
Transfection
1
1999
940
0.030
 Why?
Retroperitoneal Neoplasms
1
1997
28
0.030
 Why?
Intraoperative Care
1
1997
62
0.030
 Why?
Hemodynamics
2
2000
1121
0.030
 Why?
Cholic Acids
1
1996
13
0.030
 Why?
Recombinant Proteins
1
1999
1370
0.030
 Why?
Veterans
1
2008
1603
0.030
 Why?
Mice, Inbred C57BL
2
2024
5992
0.030
 Why?
Carcinoma, Squamous Cell
1
2001
641
0.030
 Why?
Atherosclerosis
1
2019
409
0.030
 Why?
Lipid Metabolism
1
1999
527
0.030
 Why?
Taurine
1
1996
41
0.030
 Why?
Movement
1
1997
293
0.030
 Why?
Wound Healing
1
1998
351
0.030
 Why?
Anticoagulants
2
2016
722
0.030
 Why?
Dose-Response Relationship, Drug
1
1999
2027
0.030
 Why?
Contrast Media
1
1998
488
0.030
 Why?
Myocardium
1
2000
939
0.030
 Why?
Bile Acids and Salts
1
1996
164
0.030
 Why?
Dogs
1
1996
437
0.030
 Why?
Tumor Necrosis Factor-alpha
1
1999
1217
0.030
 Why?
Sarcoma
1
1997
205
0.030
 Why?
Respiratory Insufficiency
1
1998
326
0.030
 Why?
Gene Expression
1
1999
1490
0.030
 Why?
Lipids
1
1999
710
0.030
 Why?
Prevalence
1
2001
2834
0.030
 Why?
Neoplasm Recurrence, Local
1
2001
1137
0.030
 Why?
Databases, Factual
1
2019
1486
0.020
 Why?
Accidents, Traffic
2
2005
190
0.020
 Why?
Swine, Miniature
1
1993
89
0.020
 Why?
Cohort Studies
3
2012
5960
0.020
 Why?
Least-Squares Analysis
1
2012
76
0.020
 Why?
Blood Flow Velocity
2
2005
413
0.020
 Why?
Mass Screening
1
2001
1347
0.020
 Why?
DNA
1
1999
1463
0.020
 Why?
Random Allocation
1
1993
363
0.020
 Why?
Infusions, Intravenous
1
1993
423
0.020
 Why?
Magnetic Resonance Imaging
3
2003
3863
0.020
 Why?
Quality-Adjusted Life Years
1
2012
121
0.020
 Why?
Case-Control Studies
2
2014
3604
0.020
 Why?
Physician Impairment
1
1990
15
0.020
 Why?
Cross-Sectional Studies
1
2022
5868
0.020
 Why?
Polytetrafluoroethylene
2
2003
25
0.020
 Why?
Swine
1
1993
833
0.020
 Why?
Mice
2
2024
18339
0.020
 Why?
Blood Component Transfusion
1
2010
103
0.020
 Why?
Product Surveillance, Postmarketing
1
2009
72
0.020
 Why?
Confidence Intervals
1
2010
333
0.020
 Why?
Probability
1
2010
310
0.020
 Why?
Infant
1
2023
10034
0.020
 Why?
Morbidity
1
2009
323
0.020
 Why?
Advisory Committees
1
2009
228
0.020
 Why?
Medicare
1
2014
886
0.020
 Why?
Suture Techniques
1
2008
131
0.020
 Why?
Regression Analysis
1
2010
1003
0.020
 Why?
Postoperative Hemorrhage
1
2008
104
0.020
 Why?
Catheterization
1
2007
183
0.010
 Why?
Guideline Adherence
1
2010
589
0.010
 Why?
Phenotype
1
2014
3162
0.010
 Why?
Surveys and Questionnaires
1
2018
6048
0.010
 Why?
Genetic Predisposition to Disease
1
2014
2363
0.010
 Why?
Pyelonephritis, Xanthogranulomatous
1
2004
3
0.010
 Why?
Ligation
1
2004
92
0.010
 Why?
Thrombectomy
1
2004
78
0.010
 Why?
Escherichia coli Infections
1
2004
129
0.010
 Why?
Transplantation, Autologous
1
2004
290
0.010
 Why?
Washington
1
2003
147
0.010
 Why?
Popliteal Vein
1
2001
4
0.010
 Why?
Protein S Deficiency
1
2001
8
0.010
 Why?
Antithrombin III Deficiency
1
2001
8
0.010
 Why?
Adolescent
2
2006
22428
0.010
 Why?
Chronic Disease
1
2008
1813
0.010
 Why?
Protein C Deficiency
1
2001
11
0.010
 Why?
Hospitalization
1
2012
2433
0.010
 Why?
Trismus
1
2001
2
0.010
 Why?
Hospital Charges
1
2001
46
0.010
 Why?
Causality
1
2001
126
0.010
 Why?
Cellulitis
1
2001
53
0.010
 Why?
Radiotherapy Dosage
1
2001
289
0.010
 Why?
Obesity, Morbid
1
2004
281
0.010
 Why?
Creatine Kinase
1
2000
72
0.010
 Why?
Necrosis
1
2001
244
0.010
 Why?
Child, Preschool
1
1995
11787
0.010
 Why?
Eye Diseases
1
2001
94
0.010
 Why?
Chemotherapy, Adjuvant
1
2001
421
0.010
 Why?
Isoenzymes
1
2000
299
0.010
 Why?
Anesthesia, General
1
2000
118
0.010
 Why?
Rectum
1
2000
180
0.010
 Why?
Myocardial Ischemia
1
2000
285
0.010
 Why?
Cardiopulmonary Bypass
1
2000
221
0.010
 Why?
Blindness
1
1998
52
0.010
 Why?
Combined Modality Therapy
1
2001
1266
0.010
 Why?
Drug Evaluation
1
1997
79
0.010
 Why?
Neoplasm Staging
1
2001
1462
0.010
 Why?
Electrocardiography
1
2000
662
0.010
 Why?
Diabetes Complications
1
1998
222
0.010
 Why?
Heparin
1
1997
244
0.010
 Why?
Decision Making
1
2003
975
0.010
 Why?
Child
1
1995
22633
0.010
 Why?
Algorithms
1
2001
1837
0.010
 Why?
Hemorrhage
1
1998
809
0.010
 Why?
Smoking
1
1998
1472
0.010
 Why?
Matsumura's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (463) concept(s)
_
Co-Authors Expand Description
See all (3) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)